Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-15 Sale | 2024-11-19 4:15 pm | NewAmsterdam Pharma Co N.V. | NAMS | ForGrowth NAP B.V. Forbion Capital Fund IV Cooperatief U.A. Forbion IV Management B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner | 41,803 | $25.07 | $1,047,876 | 11,778,760 (Indirect) | View |
2024-11-13 Sale | 2024-11-15 4:36 pm | NewAmsterdam Pharma Co N.V. | NAMS | ForGrowth NAP B.V. Forbion Capital Fund IV Cooperatief U.A. Forbion IV Management B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner | 10,898 | $25.01 | $272,511 | 11,820,563 (Indirect) | View |
2024-10-30 Purchase | 2024-11-01 4:15 pm | enGene Holdings Inc. | ENGN | Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner | 561,797 | $8.9 | $4,999,993 | 6,798,362 (Indirect Direct) | View |
2023-12-27 Purchase | 2024-10-18 4:15 pm | enGene Holdings Inc. | ENGN | Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner | 470,633 | $6.4013 | $3,012,674 | 6,236,565 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion